QSS
IMPV

Quantitative Systematic Strategies’s Imperva, Inc. IMPV Stock Holding History

Quantitative Systematic Strategies’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,722
Closed -$566K – 880
2018
Q2 		$566K Buy
+11,722
New +$561K 0.1% 313

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's IMPV Position: Q3 2018 in Review

Quantitative Systematic Strategies sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 11,722 shares — an estimated $566K sold.

Quantitative Systematic Strategies first reported a position in IMPV in Q2 2018 and held it in 1 quarter. The position peaked at $566K in Q2 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

  • Quantitative Systematic Strategies reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,722 Imperva, Inc. shares in Q3 2018, an estimated $566K.
  • Quantitative Systematic Strategies first reported a position in Imperva, Inc. in Q2 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Imperva, Inc. position peaked at $566K in Q2 2018.
  • 168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.